What's happening across industries — from energy and finance to tech and healthcare.
After a brutal downturn, chip demand is rebounding thanks to AI and data centers. We examine which semiconductor companies are best positioned.
Read More →After a brutal 2025, solar and wind stocks are bouncing back. We examine whether the recovery has legs or if it's just a dead cat bounce.
Read More →Real estate investment trusts have been beaten down by high rates. With rate cuts on the horizon, we examine whether REITs are turning a corner.
Read More →JPMorgan, Goldman, and Citi all beat estimates. We dig into the numbers and explain what it means for the broader financial sector.
Read More →Billions in drug revenue are about to lose patent protection. We explain what the patent cliff means and which companies are most exposed.
Read More →Netflix, Disney+, and Amazon are all fighting for subscribers. We look at who's profitable, who's burning cash, and what it means for investors.
Read More →Lithium prices are down over 70% from their peak. We explore what's driving the crash, whether it's a buying opportunity, and what it means for EVs.
Read More →Cold weather and rising LNG exports have sent natural gas prices soaring. We break down the supply-demand dynamics and who wins.
Read More →When markets get volatile, utility stocks become the go-to for steady income. We look at whether utility dividends are still worth it in 2026.
Read More →High rates and tighter regulation are squeezing fintech companies. We look at who's struggling, who's adapting, and what it means for investors.
Read More →Cyberattacks are on the rise and companies are spending more to defend themselves. We look at the cybersecurity sector's growth and top players.
Read More →Gold is surging as investors flee to safety. We examine the forces pushing gold higher and whether there's still room to run.
Read More →Office vacancies are rising and property values are falling. We explain the commercial real estate crisis and its ripple effects on banks and the economy.
Read More →The FDA has been approving new drugs at a faster pace. We look at the companies benefiting and what this wave of approvals means for biotech investors.
Read More →The 5G rollout promised a revolution, but telecom stocks have lagged. We assess the state of 5G investment and whether telecoms are a value play.
Read More →Governments and tech giants are betting big on nuclear power. We explore the investment case and the companies leading the charge.
Read More →Oil has dipped below $68 amid demand concerns and ample supply. We look at what's weighing on prices and who wins and loses.
Read More →Yields are surging and bond prices are falling. We explain what's happening in the bond market and what it means for fixed income.
Read More →Get our weekly newsletter with market recaps, educational explainers, and honest takes — delivered every Sunday for free.
Subscribe Free